Lee Stanyer
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Biological Psychiatry top 10%
Papers in
-
- Alzheimer's disease research and treatments 6
- Nitric Oxide and Endothelin Effects 2
-
- Mitochondrial Function and Pathology 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 1
- Co-authors
- Andrey Y. Abramov (4 shared papers)Iain P. Hargreaves (3 shared papers)Albena T. Dinkova‐Kostova (1 shared paper)Ying Zhang (1 shared paper)Liam Baird (1 shared paper)Kira M. Holmström (1 shared paper)John M. Land (1 shared paper)Masayuki Yamamoto (1 shared paper)
- Journals
- Biochimica et Biophysica Acta (BBA) - General Subjects (3 papers)PLoS ONE (3 papers)Brain (1 paper)FEBS Letters (1 paper)Biology Open (1 paper)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Lee Stanyer
18 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Neurology 206
- Biological Psychiatry 31
- Clinical Biochemistry 81
- Neurology 92
- Rheumatology 116
Countries citing papers authored by Lee Stanyer
This map shows the geographic impact of Lee Stanyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Stanyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Stanyer more than expected).
Fields of papers citing papers by Lee Stanyer
This network shows the impact of papers produced by Lee Stanyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Stanyer. The network helps show where Lee Stanyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Stanyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 375 | |
| 2 | 2008 | 258 | |
| 3 | 2002 | 156 | |
| 4 | 2008 | 47 | |
| 5 | 2019 | 43 | |
| 6 | 2002 | 23 | |
| 7 | 2001 | 19 | |
| 8 | 2002 | 17 | |
| 9 | 2008 | 15 | |
| 10 | 2008 | 12 | |
| 11 | 2004 | 11 | |
| 12 | 2004 | 10 | |
| 13 | 2003 | 8 | |
| 14 | 2007 | 7 | |
| 15 | 1999 | 7 | |
| 16 | 2004 | 5 | |
| 17 | Is there any substitute for experience? | 2002 | 1 |
| 18 | PINK1: a novel mitochondrial protein in Parkinson's disease | 2006 | 1 |
About Lee Stanyer
Lee Stanyer is a scholar working on Physiology, Molecular Biology, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Genetics, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Advanced Glycation End Products research (4 papers), Genetics and Neurodevelopmental Disorders (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Mitochondrial Function and Pathology (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Neurology (206 citations), Biological Psychiatry (31 citations), Clinical Biochemistry (81 citations), Neurology (92 citations) and Rheumatology (116 citations). Lee Stanyer has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Andrey Y. Abramov, Iain P. Hargreaves, Albena T. Dinkova‐Kostova, Ying Zhang, Liam Baird, Kira M. Holmström, John M. Land, Masayuki Yamamoto, Annapurna Chalasani and D. J. Betteridge. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - General Subjects, PLoS ONE, Brain, FEBS Letters and Biology Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.